| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Oncocyte Corp | Chief Financial Officer | Common Stock, no par value | 150,000 | $32,235 | $0.2149 | 15 Aug 2022 | Direct |
| Oncocyte Corp | Chief Financial Officer | Option to Purchase Common Stock | 121,381 | 24 Feb 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OCX | Oncocyte Corp | 24 Feb 2023 | 1 | $0 | 4 | Chief Financial Officer | 28 Feb 2023, 16:55 |
| OCX | Oncocyte Corp | 17 Jan 2023 | 1 | $0 | 4 | Chief Financial Officer | 19 Jan 2023, 16:14 |
| OCX | Oncocyte Corp | 15 Aug 2022 | 2 | $0 | 4 | Chief Financial Officer | 17 Aug 2022, 20:19 |
| OCX | Oncocyte Corp | 01 Jun 2022 | 1 | $0 | 4 | SVP, Finance, and Interim CFO | 15 Jun 2022, 19:49 |
| OCX | Oncocyte Corp | 01 Jun 2022 | 0 | $0 | 3 | SVP, Finance, and Interim CFO | 13 Jun 2022, 17:50 |